✦ LIBER ✦

Secukinumab treatment shows a neutral effect on the lipid profile of patients with moderate to severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled, phase II study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secukinumab treatment shows a neutral im

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy and safety of secukinumab in th

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Patient-reported outcomes in moderate-to

✍ S. Tyring; J. Bagel; C. Lynde; P. Klekotka; E.H.Z. Thompson; S.R. Gandra; Y. Shi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

A randomized, double-blind, placebo-cont

✍ A.B. Gottlieb; R.G. Langley; B.E. Strober; K.A. Papp; P. Klekotka; K. Creamer; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Impact of ustekinumab on health-related

✍ Hidemi NAKAGAWA; Brad SCHENKEL; Mai KATO; Takeshi KATO; Atsuyuki IGARASHI; The J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB

A phase IV randomized, double-blind, pla

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB